These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2022160)

  • 21. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS; Stead H; Wallemark CB; Nicholson PA
    J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
    Umegaki E; Kuramoto T; Kojima Y; Nouda S; Ishida K; Takeuchi T; Inoue T; Tokioka S; Higuchi K
    Intern Med; 2014; 53(4):283-90. PubMed ID: 24531083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of microencapsulated vs. enteric-coated acetylsalicylic acid on gastric and duodenal mucosa: an endoscopic study.
    Malfertheiner P; Stanescu A; Rogatti W; Ditschuneit H
    J Clin Gastroenterol; 1988 Jun; 10(3):269-72. PubMed ID: 2980760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
    Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
    Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
    Laine L; Sloane R; Ferretti M; Cominelli F
    Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.
    Sikes DH; Agrawal NM; Zhao WW; Kent JD; Recker DP; Verburg KM
    Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1101-11. PubMed ID: 12362101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
    Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A
    Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers.
    Blondon H; Barbier JP; Mahé I; Deverly A; Kolsky H; Bergmann JF
    Fundam Clin Pharmacol; 2000; 14(2):155-7. PubMed ID: 10796063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
    Moberly JB; Harris SI; Riff DS; Dale JC; Breese T; McLaughlin P; Lawson J; Wan Y; Xu J; Truitt KE
    Dig Dis Sci; 2007 Feb; 52(2):442-50. PubMed ID: 17216336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa.
    Lehtola J; Sipponen P
    Scand J Rheumatol; 1977; 6(2):97-102. PubMed ID: 331465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury.
    Scheiman JM; Cryer B; Kimmey MB; Rothstein RI; Riff DS; Wolfe MM
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):290-5. PubMed ID: 15067622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the protective effects of roxatidine and misoprostol on diclofenac gastroduodenal pathology. An endoscopic, controlled study of volunteers].
    Müller P; Jackisch P; Simon B
    Arzneimittelforschung; 1994 Oct; 44(10):1127-9. PubMed ID: 7818585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
    Lanza F; Sahba B; Schwartz H; Winograd S; Torosis J; Quan H; Reyes R; Musliner T; Daifotis A; Leung A
    Am J Gastroenterol; 2002 Jan; 97(1):58-64. PubMed ID: 11808969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic comparison.
    Aabakken L; Olaussen B; Mowinckel P; Osnes M
    Scand J Gastroenterol; 1992 Dec; 27(12):1049-54. PubMed ID: 1475622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of enprostil on the gastroduodenal mucosa of healthy volunteers.
    Lanza FL; Robinson MG; Isenberg JI; Basuk PM; Karlin DA
    Aliment Pharmacol Ther; 1990 Dec; 4(6):601-13. PubMed ID: 2129647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alendronate on gastric and duodenal mucosa.
    Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
    Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind study evaluating by endoscopy the tolerability of nimesulide and diclofenac on the gastric mucosa in osteoarthritic patients.
    Porto A; Almeida H; Cunha MJ; Macciocchi A
    Eur J Rheumatol Inflamm; 1994; 14(4):33-8. PubMed ID: 7601181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endoscopic studies on the gastric tolerance of paracetamol and acetylsalicylic acid. A placebo-controlled, double-blind study in healthy volunteers].
    Müller P; Simon B; Weise D; Dammann HG
    Arzneimittelforschung; 1990 Mar; 40(3):316-8. PubMed ID: 2346543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.